Intracranial metastatic esthesioneuroblastoma responsive to temozolomide.
Successful management of a heavily pretreated 58-year-old woman with metastatic esthesioneuoblastoma using temozolomide is reported. There is no standard treatment of this tumors with extra- and intracranial manifestations. The response, long term stability and high quality of life using temozolomide for this tumor entity should be recognized.
Wick
Wolfgang
W
Department of Neurology, University of Tübingen Medical School, Tübingen, Germany. wolfgang.wick@uni-tuebingen.de
Wick
Antje
A
Küker
Wilhelm
W
Dichgans
Johannes
J
Weller
Michael
M
D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000556:secondary; D003606:Dacarbazine / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D018304:Esthesioneuroblastoma, Olfactory / Q000188:drug therapy* / Q000556:secondary; D005260:Female; D006801:Humans; D008875:Middle Aged; D009296:Nasal Cavity / Q000473:pathology*; D009669:Nose Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011788:Quality of Life; D000077204:Temozolomide
D018906:Antineoplastic Agents, Alkylating; D003606:Dacarbazine; D000077204:Temozolomide